108 related articles for article (PubMed ID: 10907535)
1. Erythropoietic protoporphyria: treatment with antioxidants and potential cure with gene therapy.
Mathews-Roth MM
Methods Enzymol; 2000; 319():479-84. PubMed ID: 10907535
[No Abstract] [Full Text] [Related]
2. Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy.
Pawliuk R; Bachelot T; Wise RJ; Mathews-Roth MM; Leboulch P
Nat Med; 1999 Jul; 5(7):768-73. PubMed ID: 10395321
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection.
Richard E; Mendez M; Mazurier F; Morel C; Costet P; Xia P; Fontanellas A; Geronimi F; Cario-André M; Taine L; Ged C; Malik P; de Verneuil H; Moreau-Gaudry F
Mol Ther; 2001 Oct; 4(4):331-8. PubMed ID: 11592836
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietic protoporphyria treated with narrow-band (TL-01) UVB phototherapy.
Warren LJ; George S
Australas J Dermatol; 1998 Aug; 39(3):179-82. PubMed ID: 9737047
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of the metabolic defect in erythropoietic protoporphyria by expression of human ferrochelatase in cultured cells.
Mathews-Roth MM; Michel JL; Wise RJ
J Invest Dermatol; 1995 Apr; 104(4):497-9. PubMed ID: 7706765
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for erythropoietic protoporphyria.
Todd DJ
Br J Dermatol; 2000 Apr; 142(4):826-7. PubMed ID: 10792248
[No Abstract] [Full Text] [Related]
7. Photo(chemo)therapy and general management of erythropoietic protoporphyria.
Roelandts R
Dermatology; 1995; 190(4):330-1. PubMed ID: 7655119
[TBL] [Abstract][Full Text] [Related]
8. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells.
Fontanellas A; Mendez M; Mazurier F; Cario-André M; Navarro S; Ged C; Taine L; Géronimi F; Richard E; Moreau-Gaudry F; Enriquez De Salamanca R; de Verneuil H
Gene Ther; 2001 Apr; 8(8):618-26. PubMed ID: 11320408
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations.
Poh-Fitzpatrick MB; Wang X; Anderson KE; Bloomer JR; Bolwell B; Lichtin AE
J Am Acad Dermatol; 2002 Jun; 46(6):861-6. PubMed ID: 12063482
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietic protoporphyria (EPP) at 40. Where are we now?
Sarkany RP
Photodermatol Photoimmunol Photomed; 2002 Jun; 18(3):147-52. PubMed ID: 12207680
[TBL] [Abstract][Full Text] [Related]
11. Ferrochelatase cDNA delivered by adenoviral vector corrects biochemical defect in protoporphyric cells.
Magness ST; Brenner DA
Hum Gene Ther; 1995 Oct; 6(10):1285-90. PubMed ID: 8590732
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria.
Imoto S; Tanizawa Y; Sato Y; Kaku K; Oka Y
Br J Haematol; 1996 Jul; 94(1):191-7. PubMed ID: 8757534
[TBL] [Abstract][Full Text] [Related]
13. Fetal detoxification of maternal protoporphyria.
Shenefelt PD
J Am Acad Dermatol; 1998 Jan; 38(1):129-30. PubMed ID: 9448224
[No Abstract] [Full Text] [Related]
14. Beta-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of beta-carotene.
von Laar J; Stahl W; Bolsen K; Goerz G; Sies H
J Photochem Photobiol B; 1996 Apr; 33(2):157-62. PubMed ID: 8691357
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analysis of families with erythropoietic protoporphyria and novel mutations of the ferrochelatase gene.
Wang X; Yang L; Kurtz L; Lichtin A; DeLeo VA; Bloomer J; Poh-Fitzpatrick MB
J Invest Dermatol; 1999 Jul; 113(1):87-92. PubMed ID: 10417624
[TBL] [Abstract][Full Text] [Related]
16. Participation of singlet oxygen in ultraviolet-a-induced lipid peroxidation in mouse skin and its inhibition by dietary beta-carotene: an ex vivo study.
Bando N; Hayashi H; Wakamatsu S; Inakuma T; Miyoshi M; Nagao A; Yamauchi R; Terao J
Free Radic Biol Med; 2004 Dec; 37(11):1854-63. PubMed ID: 15528044
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of the molecular biology of erythropoietic protoporphyria.
Todd DJ
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):207-13. PubMed ID: 9883431
[TBL] [Abstract][Full Text] [Related]
18. Recessive inheritance of erythropoietic protoporphyria with liver failure.
Sarkany RP; Alexander GJ; Cox TM
Lancet; 1994 Jun; 343(8910):1394-6. PubMed ID: 7910885
[TBL] [Abstract][Full Text] [Related]
19. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria.
Meerman L; Koopen NR; Bloks V; Van Goor H; Havinga R; Wolthers BG; Kramer W; Stengelin S; Müller M; Kuipers F; Jansen PL
Gastroenterology; 1999 Sep; 117(3):696-705. PubMed ID: 10464147
[TBL] [Abstract][Full Text] [Related]
20. A novel ferrochelatase gene mutation (IVS1-2 A-->C) in erythropoietic protoporphyria.
Lew W
J Invest Dermatol; 2003 Aug; 121(2):425-7. PubMed ID: 12880438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
